- Home
- RDZN vs TLSA Comparison
RDZN vs TLSA Comparison
Compare RDZN & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDZN
- TLSA
- Stock Information
- Founded
- RDZN 2015
- TLSA 2013
- Country
- RDZN United States
- TLSA United Kingdom
- Employees
- RDZN N/A
- TLSA N/A
- Industry
- RDZN Blank Checks
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- RDZN Finance
- TLSA Health Care
- Exchange
- RDZN Nasdaq
- TLSA Nasdaq
- Market Cap
- RDZN 86.1M
- TLSA 87.8M
- IPO Year
- RDZN N/A
- TLSA 2000
- Fundamental
- Price
- RDZN $1.11
- TLSA $0.94
- Analyst Decision
- RDZN Strong Buy
- TLSA
- Analyst Count
- RDZN 2
- TLSA 0
- Target Price
- RDZN $5.00
- TLSA N/A
- AVG Volume (30 Days)
- RDZN 178.0K
- TLSA 640.2K
- Earning Date
- RDZN 02-12-2025
- TLSA 05-09-2025
- Dividend Yield
- RDZN N/A
- TLSA N/A
- EPS Growth
- RDZN N/A
- TLSA N/A
- EPS
- RDZN N/A
- TLSA N/A
- Revenue
- RDZN $42,893,256.00
- TLSA N/A
- Revenue This Year
- RDZN $4.52
- TLSA N/A
- Revenue Next Year
- RDZN $53.72
- TLSA N/A
- P/E Ratio
- RDZN N/A
- TLSA N/A
- Revenue Growth
- RDZN 2.79
- TLSA N/A
- 52 Week Low
- RDZN $0.71
- TLSA $0.41
- 52 Week High
- RDZN $6.67
- TLSA $1.91
- Technical
- Relative Strength Index (RSI)
- RDZN 48.30
- TLSA 40.18
- Support Level
- RDZN $0.96
- TLSA $1.01
- Resistance Level
- RDZN $1.38
- TLSA $1.13
- Average True Range (ATR)
- RDZN 0.13
- TLSA 0.13
- MACD
- RDZN 0.02
- TLSA -0.05
- Stochastic Oscillator
- RDZN 32.14
- TLSA 3.19
About RDZN Roadzen Inc.
Roadzen Inc is an insurance technology company on a mission to transform global auto insurance powered by advanced AI. Its clients comprise major insurers, fleets, and carmakers to small fleets, brokers, and insurance agents that use Roadzen's technology to build new products, sell insurance, process claims, and improve road safety. The company's work in telematics and computer vision has earned recognition as an AI innovator by publications such as Forbes, Fortune, and Financial Express.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.